The current patent teaches that exogenous neural stem cells can migrate to the area of various brain cancers. The patent covers the use of neural stem cells as a trojan horse to carry enzymes that activate prodrugs into active drugs in proximity to a tumor in order to induce cancer cell death.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.